Arkis BioSciences Closes $3.4M Series-A Investment

Arkis announced this morning the closing of its $3.4 million Series-A investment. The Series-A funding was led by Innova Memphis, followed by Angel Capital Group, the Lighthouse Fund, and other private investors. Arkis’ new financing will accelerate the commercialization of its less-invasive neurosurgical instrumentation and the market release of its in-licensed Endexo® technology. 

View the full press release

Arkis a Bronze sponsor of the 2016 annual HA conference.

Learn more about Arkis’ new innovative treatment devices at this year’s Hydrocephalus Association’s National Conference in Minneapolis, June 16 - 19.  Arkis is a Bronze sponsor of this year’s 14th annual conference and will be exhibiting at booth 8.   To learn more about the Hydrocephalus Association Conference, please visit

Read More

Arkis BioSciences exhibits at AANS 2016

Join Arkis this year at booth 4900 of the AANS where we will be presenting Arkis' new Tunneling Guidewire and the company's plans for the launch of Endexo External Ventricular Drainage catheters.  To learn more about the American Academy of Neurological Sciences, visit  

Read More

Arkis featured in Teknovation for launch of Tunneling Guidewire

October 19, 2015: Pershing Yoakley and Associates' Tom Ballard interviews Arkis' CEO, Chad Seaver, on the company's plans for launching its first surgical innovation, the Tunneling GuidewireTM.  

View the full news article

Arkis to present at the New York Venture Summit June 24th!

Arkis is proud to have been selected for the NYVS this year and is scheduled to present June 24th in the conference's Life Sciences round beginning at 10 AM EDT.  We hope to see you there! 

Read More

Arkis BioSciences completes FDA registration and listing!

March 23, 2015

Arkis BioSciences completed FDA establishment registration Monday and listing of its Tunneling Guidewire instrument facilitating market introduction.  Arkis' Tunneling Guidewire now offers physicians and hydrocephalus patients a next generation surgical solution for less invasive shunt implantations, reducing neck incisions and surgical durations.

Arkis invited to present at the 15th annual New York Venture Summit!

Arkis is honored to be invited to present at this year's NY Venture Summit, June 23 - 24th, at The Digital Sandbox.  Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.

Arkis BioSciences selected as a Top 50 Showcase Company at SEVC 2015!

Join Arkis at this year's Southeastern Venture Conference where we'll be presenting as a Top 50 Showcase Company in Charlotte, NC and sharing exciting news of Arkis' latest offerings including its Tunneling Guidewire surgical instrument, providing less invasive shunt implantations! 

Read More

Arkis presenting the latest at the 2015 annual SEMDA conference...

Arkis will be sharing the latest company news at this year's SEMDA annual conference for "Smart Devices + Smart Medicine" March 31st and April 1st, 2015 where we'll be speaking about Arkis' exclusive offering of its new FDA listed Tunneling Guidewire surgical instrument - the first of its kind for less invasive shunt procedures, as well as other innovations forthcoming from Arkis, including its groundbreaking anti-coagulant lumens and non-invasive long-term intracranial pressure sensing for Bluetooth LE assessment of ICP. 

Read More

Arkis BioSciences selected to present at VS West 2015!

Join Arkis in the valley! Arkis selected to present among the nation's Top 50 Innovators convening at Venture Summit West, San Francisco, February 10th-11th. Arkis will be presenting exciting news along with the latest updates of our commitment for revolutionizing patient care!



Contact Us

Address:  P.O. Box 9815, 1 Momentum Way, Knoxville, TN 37920   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap


Go to top